In his weekly clinical update Dr. Griffin discusses high points of the multi-national monkeypox outbreaks, monkeypox virus genome mutations, possible occupational infection of healthcare workers with monkeypox virus, rates of monkeypox cases by vaccination status, protection of SARS-CoV-2 infection against reinfection, Paxlovid significantly reduces COVID-19 hospitalizations and deaths, and rebound in COVID19 with and without Paxlovid treatment.

Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email

Become a patron of TWiV!

Links for this episode

Research assistant position with Amy Rosenfeld (pdf)
Support MicrobeTV with a Spike t-shirt at Vaccinated.US
Multi-National Monkeypox outbreak (CDC)
Mutation of the Monkeypox Virus (Nature)
Occupational infection of Healthcare workers with Monkeypox (CDC)
Rates of Monkeypox cases by vaccination status (CDC)
Protection of SARS-CoV-2 natural infection against reinfection (CMI)
PAXLOVID patient eligibility screening checklist (FDA)
Paxlovid reduces COVID19 hospitalizations & deaths (EPIC)
Paxlovid rebound in COVID19 (NEJM)
Remdesivir fact sheet for providers (Veklury)
Bebtelovimab fact sheet for providers (FDA)
Dr. Griffin’s treatment guide (pdf)
Contribute to Floating Doctors fundraiser at PWB
Letters read on TWiV 943
Timestamps by Jolene. Thanks!

Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv

TWiV 943: Clinical update with Dr. Daniel Griffin